drugset / Trial / NCT00006481

Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer

NCT00006481 ↗

Supportive care

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells, but may cause skin irritation and inflammation. Biafine cream may be effective in lessening side effects caused by radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of Biafine cream in reducing side effects of radiation therapy in patients receiving treatment for head and neck cancer.

Timeline

Start
2000-10
Primary completion
2002-08
Completion
—

Outcome

Missed primary endpoint

paper The results of this trial demonstrate no advantage for the use of trolamine in reducing the incidence of grade 2 or higher radiation dermatitis PMID 16648511 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Trolamine Unknown — Topical